The project aims to design computational “tool kits” that can speed development of multi-virus vaccines targeting some of the greatest infectious threats to human health.

Preliminary results of a clinical trial of 4-phenylbutyrate (PBA) “show a significant reduction in seizure activity among participants.”

Research could lead to improved diagnosis and the first effective treatment for the disorder, called “clonal hematopoiesis of indeterminate potential,” or CHIP. 

The list recognizes both the scientific achievements of individual scientists and “their profound impact on tackling broader societal challenges.”

Sponsored by the Department of Biomedical Informatics, the symposium showcased the work of the department’s center for AI Discovery and Vigilance to Accelerate Innovation and Clinical Excellence.

Crowe and his colleagues have developed cutting-edge technologies to isolate and study antiviral antibodies.